XML 17 R4.htm IDEA: XBRL DOCUMENT v3.25.3
Interim Condensed Consolidated Statements of Income - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Net revenues and financial income $ 7,409 $ 5,312 $ 20,134 $ 14,718
Cost of net revenues and financial expenses (4,200) (2,873) (11,060) (7,890)
Gross profit 3,209 2,439 9,074 6,828
Operating expenses:        
Product and technology development (567) (504) (1,685) (1,422)
Sales and marketing (833) (566) (2,183) (1,555)
Provision for doubtful accounts (815) (507) (2,108) (1,331)
General and administrative (270) (305) (786) (709)
Total operating expenses (2,485) (1,882) (6,762) (5,017)
Income from operations 724 557 2,312 1,811
Other income (expenses):        
Interest income and other financial gains 49 43 130 107
Interest expense and other financial losses (35) (40) (110) (117)
Unrealized foreign currency losses, net (102) (40) (274) (132)
Net income before income tax expense 636 520 2,058 1,669
Income tax expense (215) (123) (620) (397)
Net income $ 421 $ 397 $ 1,438 $ 1,272
Basic earnings per share        
Basic net income available to shareholders per common share (in dollars per share) $ 8.32 $ 7.83 $ 28.37 $ 25.09
Weighted average of outstanding common shares (in shares) 50,697,265 50,697,438 50,697,338 50,697,442
Diluted earnings per share        
Diluted net income available to shareholders per common share (in dollars per share) $ 8.32 $ 7.83 $ 28.37 $ 25.09
Weighted average of outstanding common shares (in shares) 50,697,284 50,697,438 50,697,344 50,697,442
Service        
Net revenues and financial income $ 6,476 $ 4,760 $ 17,760 $ 13,307
Product        
Net revenues and financial income $ 933 $ 552 $ 2,374 $ 1,411